Ideally, the relevant clinical Sponsor processes should be established before the activities they govern begin. Waiting until immediately before the first participant is enrolled can create unnecessary pressure and leave little time for personnel to become familiar with new procedures. The transition should therefore be planned as part of your preparation for clinical development.

Not necessarily. Many fundamental Sponsor and GCP responsibilities apply throughout clinical development. The QMS should therefore be based primarily on the activities performed, risks involved and responsibilities of the sponsor rather than simply the numerical clinical phase. OZQA combines Phase I and Phase II into one scalable QMS framework for this reason.

No. If your organisation already has suitable core quality processes, the Phase I/II module can be used to supplement your existing QMS. If you are starting without an established quality framework, the Complete Phase I/II QMS combines the foundational QMS with the clinical module. OZQA can review your existing system to determine which approach is most appropriate.

Yes. Your CRO's QMS governs the CRO's organisation and processes. The sponsor still needs appropriate systems for its own responsibilities and for maintaining oversight of activities transferred to service providers. Your Sponsor QMS defines how your organisation manages that responsibility.

For some delegated operational activities, the CRO may appropriately work according to its own controlled procedures. However, the sponsor still needs to define how activities are delegated and how appropriate oversight is maintained. The appropriate approach depends on the activity, contractual arrangements, risk and operating model. OZQA can help avoid unnecessary duplication between Sponsor and CRO procedures.

No. The QMS should be proportionate to the sponsor's activities, risks and organisational complexity. A virtual biotech conducting one early phase study through a CRO should not automatically need the same internal procedural infrastructure as a global pharmaceutical company running dozens of trials. The regulatory responsibilities remain, but the way they are implemented can be proportionate.

No. If you already have quality procedures in place, OZQA can review your existing documentation and identify which documents can be retained, updated or supplemented. There is usually little value in replacing a suitable existing process simply for the sake of standardisation. The objective is to create a coherent and appropriate QMS, not necessarily to replace every document with an OZQA template.

Yes, this can actually make a structured quality system particularly valuable.CROs, CDMOs, laboratories and consultants may operate under their own quality systems, but those systems control their organisations, not yours.Your company still needs appropriate processes for selecting and overseeing external providers, defining responsibilities, reviewing critical deliverables, managing risks and maintaining access to important development records.As development progresses into clinical trials, sponsor oversight becomes particularly important. ICH E6(R3) explicitly places responsibility on the sponsor for appropriate oversight of investigators and service providers.

No. OZQA is system independent. You can implement our QMS documentation within your existing document management or eQMS environment, provided the system is appropriate for its intended use and applicable regulatory requirements. If your organisation already uses a suitable platform, we can help structure the QMS around your existing setup.If you do not yet have a system, OZQA can help you assess your requirements and recommend suitable eQMS solutions based on factors such as company size, development stage, regulatory requirements, workflows, integrations and budget.We do not believe every company needs the same system.The technology should support your QMS – not dictate it.

There is no single eQMS that is right for every organisation.A small preclinical biotech may be well served by a controlled SharePoint setup, while a larger clinical stage organisation may benefit from a dedicated eQMS with integrated document control, training, change control, CAPA and audit trails. OZQA can help evaluate available solutions and determine which type of system is appropriate for your current and future needs. Our QMS templates are not tied to one specific software provider, allowing you to select or change your technology without rebuilding the underlying quality framework.

Yes.The OZQA Preclinical QMS can be purchased as a ready to adapt documentation package for organisations with sufficient internal quality expertise.The package includes the core SOPs and supporting log forms needed to establish the system.If you need assistance, implementation and training support can be added separately.This means you can choose between a primarily self managed implementation and a more supported QMS implementation.

Yes. Our templates provide the starting framework, but a QMS should reflect how your organisation actually operates. OZQA can support the adaptation of procedures to your organisational structure, responsibilities, outsourced activities, development programme and document management environment. We can also help establish the QMS structure, train personnel, support implementation and go live.

Yes. All OZQA documents developed for pharmaceuticals are aligned with GxP, ICH, EMA, and FDA expectations for documentation and quality systems. They’re designed to pass audits and inspections without additional rewriting. All documentation is developed by QA professionals with real experience from biotech, clinical, and pharmaceutical companies.Our team has supported both early-phase and commercial-stage organizations through audits and regulatory submissions.

The implementation timeline depends on the size and complexity of the organisation, the number of existing processes and documents, the selected document management system and how much support is required.A small organisation starting with the OZQA Preclinical QMS can typically implement the system progressively rather than trying to introduce every process at once.OZQA can develop an implementation roadmap that prioritises the processes most relevant to your current activities and development milestones.